Latest Breaking News On - காத்தாடி பார்மா - Page 5 : comparemela.com

ADVERTISEMENT Fed. Circ. Forecast: Kite Takes Aim At Juno s $1.2B IP Win Law360 (July 1, 2021, 9:58 PM EDT) The Federal Circuit next week will hear Kite Pharma s appeal of a $1.2 billion verdict in favor of Juno Therapeutics in a case over a cancer treatment patent, marking the first time the appeals court will hear a case in-person since the start of the pandemic. Here s a look at that case plus all the other major patent cases facing the court in the coming week. The arguments on Tuesday will pit Bristol-Myers Squibb Co. s Juno and the famed cancer center Sloan Kettering against the Santa Monica, Calif.-based Kite, which Gilead Sciences Inc. bought for $11.9 billion in 2017. Two.

Santa monicaSloan ketteringBristol myers squibb coGilead sciences incFederal circuitKite pharmaJuno therapeuticsBristol myers squibbCalifornia based kiteGilead sciencesசாந்தா மோனிகாஸ்லோன் கெட்டரிங்பிரிஸ்டல் மைஸ் ஸ்க்விப்ப் இணைகிலியட் அறிவியல் இன்க்கூட்டாட்சியின் சுற்றுகாத்தாடி பார்மா